Literature DB >> 11082445

Regulation of c-Jun N-terminal kinase by the ORL(1) receptor through multiple G proteins.

A S Chan1, Y H Wong.   

Abstract

Nociceptin is an endogenous peptide that produces its biological effects by binding to the opioid receptor-like (ORL(1)) receptor. It has been shown that activation of ORL(1) receptor leads to inhibition of the adenylyl cyclase activity, but stimulation of the extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases. In this report, we demonstrate that activation of the G protein-coupled ORL(1) receptor in transfected COS-7 cells leads to stimulation of the JNK subgroup of mitogen-activated protein kinases in a Ras/Rac-dependent manner, and it was insensitive to wortmannin. This increased JNK activity was mainly mediated by PTX-sensitive G(i) proteins, and partially contributed by a PTX-insensitive component. Among all known PTX-insensitive G proteins, G(z), G(12), G(14), and G(16) seemed to have functional coupling with the ORL(1) receptor in terms of JNK activation. Stimulation of the endogenous ORL(1) receptor in NG108-15 cells also led to activation of a PTX-sensitive JNK activity in a wortmannin-insensitive manner. The induced JNK activation is accompanied by the active phosphorylation of c-Jun and activating transcription factor-2. This is the first report that demonstrates the stimulatory effect of ORL(1) receptor on JNK, and the subsequent activation of c-Jun and activating transcription factor-2.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11082445

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

1.  Epidermal growth factor differentially augments G(i)-mediated stimulation of c-Jun N-terminal kinase activity.

Authors:  Anthony S L Chan; Yung H Wong
Journal:  Br J Pharmacol       Date:  2004-06-01       Impact factor: 8.739

Review 2.  Functional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists.

Authors:  W Schröder; D G Lambert; M C Ko; T Koch
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

Review 3.  Post-translational Modifications of Opioid Receptors.

Authors:  Mariana Lemos Duarte; Lakshmi A Devi
Journal:  Trends Neurosci       Date:  2020-04-16       Impact factor: 13.837

Review 4.  Molecular mechanisms of opioid receptor-dependent signaling and behavior.

Authors:  Ream Al-Hasani; Michael R Bruchas
Journal:  Anesthesiology       Date:  2011-12       Impact factor: 7.892

5.  Agonist-selective NOP receptor phosphorylation correlates in vitro and in vivo and reveals differential post-activation signaling by chemically diverse agonists.

Authors:  Anika Mann; Lionel Moulédous; Carine Froment; Patrick R O'Neill; Pooja Dasgupta; Thomas Günther; Gloria Brunori; Brigitte L Kieffer; Lawrence Toll; Michael R Bruchas; Nurulain T Zaveri; Stefan Schulz
Journal:  Sci Signal       Date:  2019-03-26       Impact factor: 8.192

Review 6.  Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.

Authors:  Lawrence Toll; Michael R Bruchas; Girolamo Calo'; Brian M Cox; Nurulain T Zaveri
Journal:  Pharmacol Rev       Date:  2016-03-08       Impact factor: 25.468

Review 7.  Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ.

Authors:  Courtney L Donica; Hibah O Awwad; Deepak R Thakker; Kelly M Standifer
Journal:  Mol Pharmacol       Date:  2013-02-08       Impact factor: 4.436

8.  Serine 363 is required for nociceptin/orphanin FQ opioid receptor (NOPR) desensitization, internalization, and arrestin signaling.

Authors:  Nancy R Zhang; William Planer; Edward R Siuda; Hu-Chen Zhao; Lucy Stickler; Steven D Chang; Madison A Baird; Yu-Qing Cao; Michael R Bruchas
Journal:  J Biol Chem       Date:  2012-10-19       Impact factor: 5.157

Review 9.  Bidirectional Regulation of Opioid and Chemokine Function.

Authors:  Thomas J Rogers
Journal:  Front Immunol       Date:  2020-01-31       Impact factor: 7.561

10.  Mutations on the Switch III region and the alpha3 helix of Galpha16 differentially affect receptor coupling and regulation of downstream effectors.

Authors:  May Ym Yu; Maurice Kc Ho; Andrew Mf Liu; Yung H Wong
Journal:  J Mol Signal       Date:  2008-11-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.